Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 51
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 42 of 54)
- Relevance
  Sort by

Injectable Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
115 Pages
Global

From

€4170EUR$4,750USD£3,627GBP

Exocrine Pancreatic Insufficiency Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Alpha Mannosidosis Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

 Report
April 2025
400 Pages
Global

From

€4390EUR$5,000USD£3,818GBP

Atrial Fibrillation - Pipeline Insight, 2025

 Clinical Trials
July 2025
60 Pages
Global

From

€1317EUR$1,500USD£1,145GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

USA Solid Tumor Therapeutics Market Outlook to 2028

 Report
October 2023
85 Pages
United States

From

€4258EUR$4,850USD£3,704GBP

a4ß7 Integrin Antagonists Market - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Acromegaly Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Listeria Monocytogenes Infections Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4390EUR$5,000USD£3,818GBP

Gene Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
124 Pages
Global

From

€4170EUR$4,750USD£3,627GBP

Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1317EUR$1,500USD£1,145GBP

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
184 Pages
Global

From

€3951EUR$4,500USD£3,436GBP

DNA Repair Drugs: Global Markets

 Report
February 2022
112 Pages
Global

From

€4829EUR$5,500USD£4,200GBP

Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
179 Pages
Global

From

€3951EUR$4,500USD£3,436GBP

Antibody Drug Conjugates Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, Application, Target, Distribution Channel, and Geography

 Report
December 2024
286 Pages
Global

From

€3907EUR$4,450USD£3,398GBP

Cell & Gene Therapy Market - Global Forecast 2025-2030

 Report
August 2025
183 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Headache Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Anti-infective Agents Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

 Report
January 2024
188 Pages
Global

From

€3951EUR$4,500USD£3,436GBP

Ataxia Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

 Report
February 2024
210 Pages
Global

From

€2985EUR$3,400USD£2,596GBP

€3731EUR$4,250USD£3,246GBP

1,070 Results (Page 42 of 54)
- 1
- 40
- 41
- 42
- 43
- 44

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.